The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population

[21] Fouchier RA(2020)CAR T Cell therapy–related cardiovascular outcomes and management: systemic disease or direct cardiotoxicity? JACC: CardioOncology 2 97-30108

[22] Galiano M(2018)Carfilzomib-associated cardiovascular adverse events: a systematic review and meta-analysis JAMA Oncology 4 e174519-450

[23] Gorbalenya AE(2018)Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis Lancet 391 933-1964

[24] Memish ZA(2020)Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Lancet Oncol 21 335-1643

[25] Perlman S(2019)Increase in blood pressure associated with tyrosine kinase inhibitors targeting vascular endothelial growth factor JACC: CardioOncology 1 24-1034

[26] Wang C(2016)Cardiovascular toxic effects of targeted cancer therapies N Engl J Med 375 1457-e69

[27] Horby PW(2020)Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal J Natl Compr Cancer Netw 1 1-1890

[28] Hayden FG(2003)Illness in intensive care staff after brief exposure to severe acute respiratory syndrome Emerg Infect Dis 9 1205-554

[29] Gao GF(2006)Intubation of SARS patients: infection and perspectives of healthcare workers Can J Anesth 53 122-e36

[30] Yeo C(2020)Exploring the reasons for healthcare workers infected with novel coronavirus disease 2019 (COVID-19) in China J Hosp Infect 5 30101-2610

[21] Fouchier RA(2020)CAR T Cell therapy–related cardiovascular outcomes and management: systemic disease or direct cardiotoxicity? JACC: CardioOncology 2 97-30108

[22] Galiano M(2018)Carfilzomib-associated cardiovascular adverse events: a systematic review and meta-analysis JAMA Oncology 4 e174519-450

[23] Gorbalenya AE(2018)Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis Lancet 391 933-1964

[24] Memish ZA(2020)Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Lancet Oncol 21 335-1643

[25] Perlman S(2019)Increase in blood pressure associated with tyrosine kinase inhibitors targeting vascular endothelial growth factor JACC: CardioOncology 1 24-1034

[26] Wang C(2016)Cardiovascular toxic effects of targeted cancer therapies N Engl J Med 375 1457-e69

[27] Horby PW(2020)Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal J Natl Compr Cancer Netw 1 1-1890

[28] Hayden FG(2003)Illness in intensive care staff after brief exposure to severe acute respiratory syndrome Emerg Infect Dis 9 1205-554

[29] Gao GF(2006)Intubation of SARS patients: infection and perspectives of healthcare workers Can J Anesth 53 122-e36

[30] Yeo C(2020)Exploring the reasons for healthcare workers infected with novel coronavirus disease 2019 (COVID-19) in China J Hosp Infect 5 30101-2610